Bausch Health Companies Inc. BHC
Set alert
At close
Pre-market · Nov 2, 4:08 AM ET
- YTD
- +17.99%
- 1 year
- +24.05%
- Open
- 8.93
- Prev close
- 8.91
- Mkt cap
- 3.07B
- Vol
- 8.64M
- Avg vol
- 3.36M
- EPS
- -2.26
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.18
- High
- 9.04
- Forward P/E
- 1.92
- Beta
- 0.37
- Short ratio
- 4.46
- Inst. own
- 65.21%
- Dividend
- 0.00
- Ex-div date
- Nov 9, 2010
- Earnings
- Feb 17, 2027
- 50-d avg
- 6.21
- 200-d avg
- 5.70
- 1y target
- 7.70
5D chart
Events in this range
- Oct 28, 2026Earnings: 1.77; estimate 1.25; surprise 41.6%
- Oct 29, 2026Rating: RBC Capital · Sector Perform → Sector Perform
- Oct 29, 2026Rating: Jefferies · Hold → Hold
Signals (73)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 9:35 AM | 2 days ago |
| SMA: Bullish | Oct 30, 9:35 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bullish | Oct 29, 3:55 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:50 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:50 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 3:45 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 3:40 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:30 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:25 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:15 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 2:20 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:15 PM | 3 days ago |
| RSI: Overbought | Oct 29, 2:10 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:15 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:05 PM | 3 days ago |
| RSI: Overbought | Oct 29, 11:45 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:40 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:00 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:40 AM | 3 days ago |
| RSI: Overbought | Oct 28, 3:55 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:50 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:40 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:35 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 3:10 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 2:40 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:05 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 1:30 PM | 4 days ago |
| RSI: Overbought | Oct 28, 1:05 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 12:55 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:25 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:25 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:20 PM | 4 days ago |
| SMA: Bullish | Oct 28, 11:00 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 10:30 AM | 4 days ago |
| RSI: Overbought | Oct 28, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 27, 3:45 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 3:45 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 3:40 PM | 5 days ago |
| SMA: Bearish | Oct 27, 3:35 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 3:05 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:25 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 2:25 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:00 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:55 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:35 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:30 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:25 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 1:05 PM | 5 days ago |
| RSI: Oversold | Oct 27, 12:45 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:55 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:45 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:35 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 11:35 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:25 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 11:20 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:15 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:35 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 9:45 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| MACD: Buy Signal | Oct 26, 3:30 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 2:50 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:45 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 2:40 PM | 6 days ago |
| SMA: Bullish | Oct 26, 2:35 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:30 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:20 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:10 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:05 PM | 6 days ago |
| SMA: Bearish | Oct 26, 11:35 AM | 6 days ago |
| SMA: Bearish | Oct 26, 10:55 AM | 6 days ago |
News
-
3 days ago benzinga.com
Jefferies Maintains Hold on Bausch Health Companies, Raises Price Target to $8
Jefferies analyst Young Li maintains Bausch Health Companies (NYSE:BHC) with a Hold and raises the price target from $6.5 to $8.
-
3 days ago benzinga.com
RBC Capital Maintains Sector Perform on Bausch Health Companies, Raises Price Target to $10
RBC Capital analyst Douglas Miehm maintains Bausch Health Companies (NYSE:BHC) with a Sector Perform and raises the price target from $9 to $10.
3 days ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Glaukos (NYSE:GKOS) shares rose 30.8% to $237.26 during Thursday's regular session. The company's market cap stands at $10.7 billion. The company's, Q3 earnings came out yesterday. Teladoc…
3 days ago zacks.com
BHC Q3 Earnings Beat on Salix Growth, Stock Gains 9% as Outlook Rises
Bausch Health shares jump 9% as Q3 earnings top estimates, driven by Xifaxan-led Salix growth, improved profitability and raised 2026 guidance.
3 days ago benzinga.com
Huntington Ingalls, Crocs, Carvana, Insmed And Other Big Stocks Moving Higher On Thursday
Stocks rallied on strong earnings and raised guidance, led by Huntington Ingalls, Porch, Teladoc and Crocs, despite the Dow falling 150 points.
4 days ago seekingalpha.com
Bausch Health Companies Inc. (BHC) Q3 2026 Earnings Call Transcript
Bausch Health Companies Inc. ( BHC ) Q3 2026 Earnings Call October 28, 2026 5:00 PM EDT Company Participants Garen Sarafian Thomas Appio - CEO & Director Jean-Jacques Charhon - Executive VP & CFO…
4 days ago zacks.com
Bausch (BHC) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Bausch (BHC) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall…
4 days ago zacks.com
Bausch Health (BHC) Surpasses Q3 Earnings and Revenue Estimates
Bausch Health (BHC) came out with quarterly earnings of $1.77 per share, beating the Zacks Consensus Estimate of $1.08 per share. This compares to earnings of $1.16 per share a year ago.
4 days ago marketbeat.com
What Bausch Health Cos (BHC) Said on Its Q3 Earnings Call
Bausch Health Cos NYSE: BHC raised its full-year 2026 outlook for the second consecutive quarter after reporting third-quarter growth across its operating segments, led by Salix and supported by…
4 days ago benzinga.com
Bausch Health Companies Q3 2026 Earnings Call Transcript
Bausch Health Companies (NYSE:BHC) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…
-
4 days ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Lakewood-Amedex (NASDAQ:LABT) stock rose 20.4% to $0.34 during Wednesday's after-market session. Glaukos (NYSE:GKOS) stock rose 16.85% to $212.01. The company's market cap stands at $10.6…
-
4 days ago benzinga.com
Bausch Health Companies Announces $50M Buyback Plan
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that its Board of Directors has authorized a share repurchase program under which the Company may repurchase its common shares…
4 days ago prnewswire.com
Bausch Health Announces Full Redemption of 8.500% Senior Notes Due 2027
LAVAL, QC, Oct. 28, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that its subsidiary, Bausch Health Americas, Inc., will issue an irrevocable notice of…
4 days ago prnewswire.com
Bausch Health Announces US$50 Million Share Repurchase Program
LAVAL, QC, Oct. 28, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that its Board of Directors has authorized a share repurchase program under which the Company…
-
4 days ago benzinga.com
Bausch Health Companies Raises FY2026 Sales Guidance from $10.790B-$11.040B to $10.975B-$11.175B vs $10.927B Est
Bausch Health Companies (NYSE:BHC) raises FY2026 sales outlook from $10.790 billion-$11.040 billion to $10.975 billion-$11.175 billion vs $10.927 billion estimate.
-
4 days ago benzinga.com
Bausch Health Companies Q3 Adj. EPS $1.77 Beats $1.29 Estimate, Sales $2.941B Beat $2.757B Estimate
Bausch Health Companies (NYSE:BHC) reported quarterly earnings of $1.77 per share which beat the analyst consensus estimate of $1.29 by 37.21 percent. This is a 52.59 percent increase over earnings…
4 days ago prnewswire.com
BAUSCH HEALTH ANNOUNCES THIRD QUARTER 2026 RESULTS, RAISES GUIDANCE
Third Quarter Consolidated Revenues of $2.94 billion, up 10% on a Reported basis and 8% on an Organic1 basis over the prior year period GAAP Net Income Attributable to Bausch Health of $436 million…
6 days ago zacks.com
BHC Q3 Earnings Preview: Here's What You Should Know
Bausch Health reports Q3 2026 results on Oct. 28, with $2.75 billion in expected sales. Explore key segment drivers and mixed earnings surprise history.
-
1 week ago benzinga.com
Bausch Health Canada Announces Expanded Public Reimbursement For PrOKEDI 75 Mg And 100 Mg, With Coverage Now Available In Seven Provinces And Multiple Federal Drug Plans
PrOKEDI® is now listed in Ontario, Quebec, British Columbia, Alberta, Saskatchewan, Nova Scotia and Prince Edward Island, as well as through federal drug plans administered by the Non-Insured Health…
2 weeks ago benzinga.com
Why Is Bausch + Lomb Stock Falling Monday?
Bausch + Lomb stock drops 10% following sudden CEO departure, despite raising full-year 2026 EBITDA guidance.
-
2 weeks ago benzinga.com
Bausch + Lomb Appoints Chairman Thomas J. Appio As Interim CEO, Effective Immediately; Company And Its Parent Bausch Health Expect To Raise FY26 Adjusted EBITDA Guidance, Excluding Acquired IPR&D
Preliminary Update on 2026 Guidance2Based on preliminary third-quarter results, Bausch + Lomb and Bausch Health currently expect to raise full-year 2026 adjusted EBITDA excluding Acquired IPR&D1…